392 related articles for article (PubMed ID: 33148274)
1. Eukaryotic translation initiation factors as promising targets in cancer therapy.
Hao P; Yu J; Ward R; Liu Y; Hao Q; An S; Xu T
Cell Commun Signal; 2020 Nov; 18(1):175. PubMed ID: 33148274
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic translation initiation factors and cancer.
Ali MU; Ur Rahman MS; Jia Z; Jiang C
Tumour Biol; 2017 Jun; 39(6):1010428317709805. PubMed ID: 28653885
[TBL] [Abstract][Full Text] [Related]
3. Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.
Yin JY; Dong Z; Liu ZQ; Zhang JT
Biosci Rep; 2011 Feb; 31(1):1-15. PubMed ID: 20964625
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factors in cancer development and progression.
Spilka R; Ernst C; Mehta AK; Haybaeck J
Cancer Lett; 2013 Oct; 340(1):9-21. PubMed ID: 23830805
[TBL] [Abstract][Full Text] [Related]
5. Translation initiation in cancer at a glance.
Smith RCL; Kanellos G; Vlahov N; Alexandrou C; Willis AE; Knight JRP; Sansom OJ
J Cell Sci; 2021 Jan; 134(1):. PubMed ID: 33441326
[TBL] [Abstract][Full Text] [Related]
6. Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis.
Rubio A; Garland GD; Sfakianos A; Harvey RF; Willis AE
Semin Cancer Biol; 2022 Nov; 86(Pt 3):151-165. PubMed ID: 35487398
[TBL] [Abstract][Full Text] [Related]
7. Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers.
Lineham E; Spencer J; Morley SJ
Future Med Chem; 2017 Sep; 9(13):1539-1555. PubMed ID: 28841037
[TBL] [Abstract][Full Text] [Related]
8. eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways.
Shahbazian D; Parsyan A; Petroulakis E; Hershey J; Sonenberg N
Cell Cycle; 2010 Oct; 9(20):4106-9. PubMed ID: 20948310
[TBL] [Abstract][Full Text] [Related]
9. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
[TBL] [Abstract][Full Text] [Related]
10. Signalling to eIF4E in cancer.
Siddiqui N; Sonenberg N
Biochem Soc Trans; 2015 Oct; 43(5):763-72. PubMed ID: 26517881
[TBL] [Abstract][Full Text] [Related]
11. Translation control of mRNAs encoding mammalian translation initiation factors.
Andreev DE; Dmitriev SE; Loughran G; Terenin IM; Baranov PV; Shatsky IN
Gene; 2018 Apr; 651():174-182. PubMed ID: 29414693
[TBL] [Abstract][Full Text] [Related]
12. Methods for studying signal-dependent regulation of translation factor activity.
Wang X; Proud CG
Methods Enzymol; 2007; 431():113-42. PubMed ID: 17923233
[TBL] [Abstract][Full Text] [Related]
13. Translation factors and ribosomal proteins control tumor onset and progression: how?
Loreni F; Mancino M; Biffo S
Oncogene; 2014 Apr; 33(17):2145-56. PubMed ID: 23644661
[TBL] [Abstract][Full Text] [Related]
14. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
Pelletier J; Graff J; Ruggero D; Sonenberg N
Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
[TBL] [Abstract][Full Text] [Related]
15. Role of RONS and eIFs in Cancer Progression.
Salaheldin YA; Mahmoud SSM; Ngowi EE; Gbordzor VA; Li T; Wu DD; Ji XY
Oxid Med Cell Longev; 2021; 2021():5522054. PubMed ID: 34285764
[TBL] [Abstract][Full Text] [Related]
16. Translation regulation as a therapeutic target in cancer.
Grzmil M; Hemmings BA
Cancer Res; 2012 Aug; 72(16):3891-900. PubMed ID: 22850420
[TBL] [Abstract][Full Text] [Related]
17. Cryptotanshinone deregulates unfolded protein response and eukaryotic initiation factor signaling in acute lymphoblastic leukemia cells.
Wu CF; Seo EJ; Klauck SM; Efferth T
Phytomedicine; 2016 Feb; 23(2):174-80. PubMed ID: 26926179
[TBL] [Abstract][Full Text] [Related]
18. New Pancreatic Cancer Biomarkers eIF1, eIF2D, eIF3C and eIF6 Play a Major Role in Translational Control in Ductal Adenocarcinoma.
Golob-Schwarzl N; Puchas P; Gogg-Kamerer M; Weichert W; Göppert B; Haybaeck J
Anticancer Res; 2020 Jun; 40(6):3109-3118. PubMed ID: 32487605
[TBL] [Abstract][Full Text] [Related]
19. Cell Fate Control by Translation: mRNA Translation Initiation as a Therapeutic Target for Cancer Development and Stem Cell Fate Control.
Kim HJ
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31671902
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of Eukaryotic Translation Initiation Factors (eIFs) in Endometrial Cancer.
Smolle MA; Czapiewski P; Lapińska-Szumczyk S; Majewska H; Supernat A; Zaczek A; Biernat W; Golob-Schwarzl N; Haybaeck J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
